Utility of paraffin section immunohistochemistry for C-KIT (CD117) in the differential diagnosis of systemic mast cell disease involving the bone marrow

American Journal of Surgical Pathology

Volumn 24, Issue 1, 2000, Pages 81-91

  Natkunam, Yasodha ^a   Rouse, Robert V ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Bone marrow; C KIT; CD117; Immunohistochemistry; Mast cell; Paraffin

Indexed keywords

PARAFFIN; TYROSINE KINASE RECEPTOR;

ADULT; AGED; ARTICLE; BONE MARROW DISEASE; CELL INFILTRATION; DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPHOMA; MALE; MAST CELL; MYELOID LEUKEMIA; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BONE MARROW; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MAST CELLS; MASTOCYTOSIS; MIDDLE AGED; PARAFFIN EMBEDDING; PROTO-ONCOGENE PROTEINS C-KIT;

EID: 0033982484     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200001000-00010     Document Type: Article

References (52)

1. Anderson DM, Lyman SD, Baird A, et al. Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell 1990;63:235-43.
2. Arber DA, Tamayo R, Weiss LM. Paraffin section detection of the C-KIT gene product (CDI 17) in human tissues: value in the diagnosis of mast cell disorders. Hum Pathol 1998;29:498-504.
3. Ashman LK, Cambareri AC, To LB, Levinsky RJ, Juttner CA. Expression of the YB5.B8 antigen (C-KIT proto-oncogene product) in normal human bone marrow. Blood 1991;78:30-7.
4. Beghini A, Larizza L, Cairoli R, Morra E. C-KIT activating mutations and mast cell proliferation in human leukemia. Blood 1998; 92:701-2.
5. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 1985;103:620-5.
6. Besmer P, Murphy JE, George PC, et al. A new acute transforming feline retrovirus and relationship of its oncogene V-KIT with the protein kinase gene family. Nature 1986;320:415-21.
7. Cascavilla N, Musto P, D'Arena G, et al. CD117 (C-KIT) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype. Haematologica 1998;83:392-7.
8. Chan JK, Banks PM, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms proposed by the International Lymphoma Study Group. A summary version. Am J Clin Pathol 1995;103:543-60.
9. Copeland NG, Gilbert DJ, Cho BC, et al. Mast cell growth factor maps near the steel locus on mouse chromosome 10 and is deleted in a number of steel alleles. Cell 1990;63:175-83.
10. Escribano L, Orfao A, Diaz-Agustin B, et al. Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications. Blood 1998;91:2731-6.
11. Gaili SJ, Tsai M, Gordon JR, Geissler EN, Wershil BK. Analyzing mast cell development and function using mice carrying mutations at W/C-KIT or Sl/MGF (SCF) loci. Ann N Y Acad Sci 1992;664: 69-88.
12. Galli SJ, Tsai M, Wershil BK. The C-KIT receptor, stem cell factor, and mast cells. What each is teaching us about the others. Am J Pathol 1993;142:965-74.
13. Geissler EN, Liao M, Brook JD, et al. Stem cell factor (SCF), a novel hematopoietic growth factor and ligand for C-KIT tyrosine kinase receptor, maps on human chromosome 12 between 12q14.3 and 12qter. Somat Cell Mol Genet 1991;17:207-14.
14. Geissler EN, Ryan MA, Housman DE. The dominant-white spotting (W) locus of the mouse encodes the C-KIT proto-oncogene. Cell 1988;55:185-92.
15. Hines SJ, Organ C, Kornstein MJ, Krystal GW. Coexpression of the C-KIT and stem cell factor genes in breast carcinomas. Cell Growth Differ 1995;6:769-79.
16. Horny HP, Engst U, Walz RS, Kaiserling E. In situ immunophenotyping of lymphocytes in human bone marrow: an immunohistochemical study. Br J Haematol 1989;71:313-21.
17. Horny HP, Kaiserling E. Lymphoid cells and tissue mast cells of bone marrow lesions in systemic mastocytosis: a histological and immunohistological study. Br J Haematol 1988;69:449-55.
18. Horny HP, Parwaresch MR, Lennert K. Bone marrow findings in systemic mastocytosis. Hum Pathol 1985;16:808-14.
19. Horny HP, Reimann O, Kaiserling E. Immunoreactivity of normal and neoplastic human tissue mast cells. Am J Clin Pathol 1988; 89:335-40.
20. Horny HP, Ruck M, Wehrmann M, Kaiserling E. Blood findings in generalized mastocytosis: evidence of frequent simultaneous occurrence of myeloproliferative disorders. Br J Haemalol 1990;76: 186-93.
21. Horny HP, Ruck P, Xiao JC, Kaiserling E. Immunoreactivity of normal and neoplastic human tissue mast cells with macrophage-associated antibodies, with special reference to the recently developed monoclonal antibody PG-M1. Hum Pathol 1993;24:355-8.
22. Horny HP, Sillaber C, Menke D, et al. Diagnostic value of immunostaining for tryptase in patients with mastocytosis. Am J Surg Pathol 1998;22:1132-40.
23. Huang E, Nocka K, Beier DR, et al. The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the C-KIT receptor, the gene product of the W locus. Cell 1990;63:225-33.
24. Ikeda H, Kanakura Y, Tamaki T, et al. Expression and functional role of the proto-oncogene C-KIT in acute myeloblastic leukemia cells. Blood 1991;78:2962-8.
25. Izquierdo MA, Van der Valk P, Van Ark-Otte J, et al. Differential expression of the C-KIT proto-oncogene in germ cell tumours. J Pathol 1995;177:253-8.
26. Kitamura Y, Go S. Decreased production of mast cells in S1/S1d anemic mice. Blood 1979;53:492-7.
27. Kitamura Y, Go S, Hatanaka K. Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood 1978;52:447-52.
28. Lammie A, Drobnjak M, Gerald W, Saad A, Cote R, Cordon-Cardo C. Expression of C-KIT and kit ligand proteins in normal human tissues. J Histochem Cytochem 1994;42:1417-25.
29. Longley BJ Jr, Morganroth GS, Tyrrell L, et al. Altered metabolism of mast-cell growth factor (C-KIT ligand) in cutaneous mastocytosis. N Engl J Med 1993;328:1302-7.
30. Longley BJ, Tyrrell L, Lu SZ, et al. Somatic C-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm. Nat Genet 1996;12:312-4.
31. Matsuda R, Takahashi T, Nakamura S, et al. Expression of the C-KIT protein in human solid tumors and in corresponding fetal and adult normal tissues. Am J Pathol 1993;142:339-46.
32. Metcalfe DD. Classification and diagnosis of mastocytosis: current status. J Invest Dermatol 1991;96:2S-4S.
33. Natali PG, Nicotra MR, Sures I, Santoro E, Bigotti A, Ullrich A. Expression of C-KIT receptor in normal and transformed human nonlymphoid tissues. Cancer Res 1992;52:6139-13.
34. Newcom SR, Gu L. Transforming growth factor beta 1 messenger RNA in Reed-Sternberg cells in nodular sclerosing Hodgkin's disease. J Clin Pathol 1995;48:160-3.
35. Ohashi A, Funasaka Y, Ueda M, Ichihashi M. C-KIT receptor expression in cutaneous malignant melanoma and benign melanotic naevi. Melanoma Res 1996;6:25-30.
36. Orfao A, Escribano L, Villarrubia J, et al. Flow cytometric analysis of mast cells from normal and pathological human bone marrow samples: identification and enumeration. Am J Pathol 1996;149: 1493-9.
37. Papayannopoulou T, Brice M, Broudy VC, Zsebo KM. Isolation of C-KIT receptor-expressing cells from bone marrow, peripheral blood, and fetal liver: functional properties and composite antigenic profile. Blood 1991;78:1403-12.
38. Parwaresch R, Horny HP, Bodewadt-Radzun, S. Mast cell disease. In: Knowles DM, ed. Neoplastic hematopathology. Baltimore: Williams & Wilkins, 1992;1485-515.
39. Pinto A, Gloghini A, Gattei V, Aldinucci D, Zagonel V, Carbone A. Expression of the C-KIT receptor in human lymphomas is restricted to Hodgkin's disease and CD30+ anaplastic large cell lymphomas. Blood 1994;83:785-92.
40. Strohmeyer T, Peter S, Hartmann M, et al. Expression of the hst-1 and C-KIT protooncogenes in human testicular germ cell tumors. Cancer Res 1991;51:1811-6.
41. Takahashi H, Saitoh K, Kishi H, Parsons PG. Immunohistochemical localisation of stem cell factor (SCF) with comparison of its receptor C-KIT proto-oncogene product (C-KIT) in melanocytic tumours. Virchows Arch 1995;427:283-8.
42. Trautmann A, Krohne G, Brocker EB, Klein CE. Human mast cells augment fibroblast proliferation by heterotypic cell-cell adhesion and action of IL-4. J Imnmnol 1998;160:5053-7.
43. Travis WD, Li CY, Bergstralh EJ. Solid and hematologic malignancies in 60 patients with systemic mast cell disease. Arch Pathol Lab Med 1989;113:365-8.
44. Travis WD, Li CY, Hoagland HC, Travis LB, Banks PM. Mast cell leukemia: report of a case and review of the literature. Mayo Clin Proc 1986;61:957-66.
45. Travis WD, Li CY, Yam LT, Bergstralh EJ, Swee RG. Significance of systemic mast cell disease with associated hmatologic disorders. Cancer 1988;62:965-72.
46. Tsuura Y, Hiraki H, Watanabe K, et al. Preferential localization of C-KIT product in tissue mast cells, basal cells of skin, epithelial cells of breast, small cell lung carcinoma and seminoma/ dysgerminoma in humans: immunohistochemical study on formalin-fixed, paraffin-embedded tissues. Virchows Arch 1994;424: 135-41.
47. Valent P, Ashman LK, Hinterberger W, et al. Mast cell typing: demonstration of a distinct hematopoietic cell type and evidence for immunophenotypic relationship to mononuclear phagocytes. Blood 1989;73:1778-85.
48. Wang C, Curtis JE, Geissler EN, McCulloch EA, Minden MD. The expression of the proto-oncogene C-KIT in the blast cells of acute myeloblastic leukemia. Leukemia 1989;3:699-702.
49. Warnke R, Weiss LM, Chan JKC, Cleary ML, Dorfman RF. Tumors of the lymph nodes and spleen. 3rd ed. Vol. 14. Washington, DC: Armed Forces Institute of Pathology. 1995;398-410.
50. Wong KF, Chan JK, Chan JC, Kwong YL, Ma SK, Chow TC. Concurrent acute myeloid leukemia and systemic mastocytosis. Am J Hematol 1991;38:243-4. [See comments.]
51. Yarden Y, Kuang WJ, Yang-Feng T, et al. Human proto-oncogene C-KIT: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 1987;6:3341-51.
52. Zsebo KM, Williams DA, Geissler EN, et al. Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the C-KIT tyrosine kinase receptor. Cell 1990;63:213-24.